The Enterprise Value as of November 2024 (TTM) for Champions Oncology, Inc. (CSBR) is 58.59M

According to Champions Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 58.59M. This represents a change of -21.50% compared to the average of 74.64M of the last 4 quarters.

Champions Oncology, Inc. (CSBR) Historical Enterprise Value (quarterly & annually)

How has CSBR Enterprise Value performed in the past?

The mean historical Enterprise Value of Champions Oncology, Inc. over the last ten years is 72.62M. The current 58.59M Enterprise Value has changed 7.97% with respect to the historical average. Over the past ten years (40 quarters), CSBR's Enterprise Value was at its highest in in the January 2021 quarter at 149.83M. The Enterprise Value was at its lowest in in the October 2016 quarter at 13.05M.

Champions Oncology, Inc. (CSBR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Champions Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Champions Oncology, Inc. (CSBR) Average Enterprise Value

How has CSBR Enterprise Value performed in the past?

The current Enterprise Value of Champions Oncology, Inc. (CSBR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Champions Oncology, Inc. (CSBR) Enterprise Value vs. Peers

How is CSBR’s Enterprise Value compared to its peers?

Champions Oncology, Inc.’s Enterprise Value is greater than Molecular Partners AG (52.74M), greater than MediciNova, Inc. (37.57M), greater than Anebulo Pharmaceuticals, Inc. (44.62M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Pardes Biosciences, Inc. (34.92M), greater than Shattuck Labs, Inc. (2.79M), less than Eliem Therapeutics, Inc. (119.64M), less than Century Therapeutics, Inc. (121.66M), greater than Aerovate Therapeutics, Inc. (50.15M), less than Adagene Inc. (71.65M), less than Acrivon Therapeutics, Inc. Common Stock (206.30M), less than Rezolute, Inc. (239.44M), greater than AN2 Therapeutics, Inc. (5.46M), greater than HCW Biologics Inc. (25.13M),

Build a custom stock screener for Champions Oncology, Inc. (CSBR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Champions Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Champions Oncology, Inc. (CSBR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Champions Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.